SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Mankind Pharma informs about change in time of conference call

26 Jul 2024 Evaluate

In continuation to its letter dated July 25, 2024, Mankind Pharma has informed that a conference call regarding acquisition of 100% stake in Bharat Serums and Vaccines scheduled today July 26, 2024 will begin at 05:00 pm (IST) instead of 04:00 pm (IST). Updated details of the Conference Call are enclosed. The same are also being uploaded on the website of the Company at www.mankindpharma.com.

The above information is a part of company’s filings submitted to BSE.

Mankind Pharma Share Price

2143.60 20.40 (0.96%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×